| | |
| | |
Stat |
Members: 3645 Articles: 2'506'133 Articles rated: 2609
27 April 2024 |
|
| | | |
|
Article overview
| |
|
Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban | Joachim P Schmitt
; Mitsuhiro Kamisago
; Michio Asahi
; Guo Hua Li
; Ferhaan Ahmad
; Ulrike Mende
; Evangelia G Kranias
; David H MacLennan
; J G Seidman
; Christine E Seidman
; | Date: |
28 Feb 2003 | Journal: | Science, 299 (5611), 1410-3 | Abstract: | Molecular etiologies of heart failure, an emerging cardiovascular epidemic affecting 4.7 million Americans and costing 17.8 billion health-care dollars annually, remain poorly understood. Here we report that an inherited human dilated cardiomyopathy with refractory congestive heart failure is caused by a dominant Arg --> Cys missense mutation at residue 9 (R9C) in phospholamban (PLN), a transmembrane phosphoprotein that inhibits the cardiac sarcoplasmic reticular Ca2+-adenosine triphosphatase (SERCA2a) pump. Transgenic PLN(R9C) mice recapitulated human heart failure with premature death. Cellular and biochemical studies revealed that, unlike wild-type PLN, PLN(R9C) did not directly inhibit SERCA2a. Rather, PLN(R9C) trapped protein kinase A (PKA), which blocked PKA-mediated phosphorylation of wild-type PLN and in turn delayed decay of calcium transients in myocytes. These results indicate that myocellular calcium dysregulation can initiate human heart failure-a finding that may lead to therapeutic opportunities. | Source: | PubMed, pmid12610310 doi: 10.1126/science.1081578 | Services: | Forum | Review | Favorites |
|
|
No review found.
Did you like this article?
Note: answers to reviews or questions about the article must be posted in the forum section.
Authors are not allowed to review their own article. They can use the forum section.
browser Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)
|
| |
|
|
|
| News, job offers and information for researchers and scientists:
| |